Utamide 50mg Tablet (Bicalutamide)
Prescription RequiredManufactured By
Intas
Pack Of
10
Salt Composition
Bicalutamide
Storage
Keep in cold place
ALL SUBSTITUTES
Bical 50mg Tablet
Bicatero 50mg Tablet
Casodex 50mg Tablet
Calutide 50mg Tablet
Tabi 50mg Tablet
Overview
Doctor prescribe Utamide 50mg Tablet for the treatment of advanced Prostate Cancer in Adult Men, often combined with LHRH agonists. It is a non steroidal anti-androgen medication. Utamide 50mg Tablet contains Bicalutamide that competitively binds to androgen receptors on prostate cancer cells, inhibiting dihydrotestosterone and testosterone effects to slow down tumor development. Doctor also prescribe it with other therapies for optimal results in managing prostate cancer progression.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | utamide |
| Generic / Active Ingredient | Bicalutamide |
| Strength | 50 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | Intas |
| Pack Size | 10 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
| Uses | Prostate Cancer |
Uses and Indications
Prostate Cancer
Side Effects of Utamide 50mg Tablet
Utamide 50mg Tablet(Bicalutamide 50mg) is a chemical salt based anticancer medication. Therefore,it has several common side effects like any other medicine. Consult your doctor, if side effects persist for longer period of time.
Common side effects of Utamide 50mg are:
● Hot Flashes
● Nausea
● Dizziness
● Weakness
● rashes
● Decreased Appetite
● Constipation
● Abdominal Pain
● Anemia
● Edema
● Nocturia
Serious Side Effects
● Liver Toxicity
● Gynecomastia
● Hematuria
● Hypersensitivity
● Cardiovascular Risks
Utamide 50mg Tablet Dosage and How To Take It
Utamide 50mg Tablet(Bicalutamide) is administered orally with water , usually with food. Duration and Dosage of the capsule depends on the cancer type, its stage and overall health of the patient on doctor's guidance. Avoid breaking, chewing and biting of capsule for effective results.
Safety Advice for Utamide 50mg Tablet
- 1. It is advisable not to consume alcohol while taking Utamide 50mg Tablet(Bicalutamide 50mg) as it can worsen the side effects. It is advised to consult your doctor for further information.
- 2. Utamide Tablet is considered unsafe for pregnancy due to fetal harm and teratogenic nature. Please consult your doctor in such condition.
- 3. Breast Feeding is not advisable during the Utamide 50mg Tablet(Bicalutamide) Course. Consult your Doctor for more information.
- 4. It is advisable not to drive, as you may feel dizzy after taking Utamide 50mg Tablet.
- 5. Share your medical history related to kidney cancer or any other issue with your doctor before taking Utamide Tablet(Bicalutamide 50mg).
- 6. Notify your doctor about any liver disease or infection before starting Utamide 50mg course.
FAQs About Utamide 50mg Tablet
Is Utamide 50mg Tablet advisable during Pregnancy?
Utamide 50mg Tablet(Bicalutamide 50mg) cause harm to growing fetus as well as is teratogenic in nature. Thus, it is not recommended during pregnancy for treatment.
Can Utamide 50mg Tablet be given with any other medicine?
Yes, Utamide 50mg(Bicalutamide) is often given with other therapies for optimal results. Consult your doctor about the same.
What should I do if I miss the Utamide 50mg Tablet dose?
Take Utamide 50mg Tablet(Bicalutamide Tablet) as soon as you remember it unless it is the time for the next dose. Do not double the dosage. Also inform your doctor about the missed dose.
How to take Utamide 50mg Tablet?
Utamide Tablet is taken orally with water without breaking, chewing or biting the capsule. It can be taken with or without food. Follow the doctor's prescribed dosage and time.
Which cancer is treated with Utamide 50mg Tablet?
Utamide 50mg Tablet(Bicalutamide) is used to treat advanced Prostate Cancer in Adult Men, often combined with LHRH agonists.
References
● Kolvenbag, G. J., Blackledge, G. R., & Gotting‐Smith, K. (1998). Bicalutamide (Casodex®) in the treatment of prostate cancer: history of clinical development. The Prostate, 34(1), 61-72.
● Kolvenbag, G. J., & Blackledge, G. R. (1996). Worldwide activity and safety of bicalutamide: a summary review. Urology, 47(1), 70-79.
● Furr, B. J. A., & Tucker, H. (1996). The preclinical development of bicalutamide: pharmacodynamics and mechanism of action. Urology, 47(1), 13-25.
● Hussain, S., Haidar, A., Bloom, R. E., Zayouna, N., Piper, M. H., & Jafri, S. M. R. (2014). Bicalutamide-induced hepatotoxicity: A rare adverse effect. The American journal of case reports, 15, 266.
Marketer Details
Intas
Author Details
Written By:
Nonish Sharma
I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More
Reviewed By:
Vaibhav Shakya
Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More
Want to know More
Check our Editor Policy
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.
